January 27, 2015 10:31 AM ET


Company Overview of Predix Pharmaceuticals Holdings, Inc.

Company Overview

As of August 16, 2006, Predix Pharmaceuticals Holdings, Inc. was acquired by EPIX Pharmaceuticals, Inc. Predix Pharmaceuticals Holdings, Inc., a pharmaceutical company, focuses on the discovery and development of small-molecule drugs that target G-protein coupled receptors (GPCRs) and ion channels. Its lead clinical-stage drug candidate, PRX-00023, completed a Phase II clinical trial in patients with generalized anxiety disorder. The company’s two other clinical-stage drug candidates include PRX-03140, a small-molecule 5-HT4 agonist for the treatment of Alzheimer’s disease; and PRX-08066, a small-molecule inhibitor, or antagonist of a specific GPCR, known as 5-HT2B for the treatment of pulmo...

4 Maguire Road

Lexington, MA 02421

United States



Key Executives for Predix Pharmaceuticals Holdings, Inc.

Predix Pharmaceuticals Holdings, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Bodyonics Ltd. United States
Psyadon Pharmaceuticals, Inc. United States
Sanofi US Services Inc. United States
DarPharma, Inc. United States
Active Organics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Predix Pharmaceuticals Holdings, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.